Systemic Lupus Erythematosus

Characteristics of Early-Onset SLE Distinguished From Mimicking Conditions

Characteristics of Early-Onset SLE Distinguished From Mimicking Conditions

By

Patients with early SLE had higher rates of unexplained fever than those with SLE-mimicking conditions.

Lupus Nephritis With Impaired Renal Function Linked to Atherosclerosis in SLE

Lupus Nephritis With Impaired Renal Function Linked to Atherosclerosis in SLE

By

Lupus nephritis in combination with impaired renal function is strongly associated with the presence of atherosclerosis in patients with systemic lupus erythematosus.

Outcomes of SLE-Associated Thrombotic Microangiopathy With Acquired ADAMTS13 Deficiency

Outcomes of SLE-Associated Thrombotic Microangiopathy With Acquired ADAMTS13 Deficiency

By

Researchers investigated the characteristics and outcomes of patients with systemic lupus erythematosus-associated thrombotic microangiopathy based on their ADAMTS13 inhibitor profiles.

High Risk for Zoster in Cyclophosphamide-Treated SLE, Systemic Vasculitis

High Risk for Zoster in Cyclophosphamide-Treated SLE, Systemic Vasculitis

By

The incidence of zoster is high in systemic vasculitis and in patients with SLE exposed to intravenous cyclophosphamide.

Epidemiology, Clinical Characteristics of Systemic Sclerosis vs SSc-SLE Overlap Syndrome

Epidemiology, Clinical Characteristics of Systemic Sclerosis vs SSc-SLE Overlap Syndrome

By

Patients with SSc-SLE overlap syndrome were younger at diagnosis, had higher rates of pulmonary arterial hypertension, and less frequently had SSc cutaneous manifestations.

Depression Risk High in Cutaneous, Systemic Lupus Erythematosus

Depression Risk High in Cutaneous, Systemic Lupus Erythematosus

By

The risk for depression was increased significantly in patients with systemic lupus erythematosus and cutaneous lupus erythematosus.

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

By

Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.

Poor Preconceptional Cardiovascular Health Affects Pregnancy Outcomes in SLE

Poor Preconceptional Cardiovascular Health Affects Pregnancy Outcomes in SLE

By

Poor preconception cardiovascular health affects pregnancy outcomes in women with SLE.

Burden of Entheseal Sonographic Changes High in Patients With SLE

Burden of Entheseal Sonographic Changes High in Patients With SLE

By

The burden of entheseal sonographic changes was significantly higher in patients with SLE vs healthy participants, especially with respect to active inflammation.

Corticosteroid Use Linked to Risk for Osteonecrosis in Systemic Lupus Erythematosus

Corticosteroid Use Linked to Risk for Osteonecrosis in Systemic Lupus Erythematosus

By

Investigators sought to identify the risk factors for osteonecrosis and to identify the minimal investigations needed to monitor the risk for osteonecrosis in patients with systemic lupus erythematosus.

Patient-Reported Disease Activity Correlates With Adverse Pregnancy Outcomes in RA

Patient-Reported Disease Activity Correlates With Adverse Pregnancy Outcomes in RA

By

A clear difference exists in the utility of patient-reported measures of disease activity in women with SLE and those with RA.

Examining the Prevalence, Characteristics of Monophasic Disease Course in SLE

Examining the Prevalence, Characteristics of Monophasic Disease Course in SLE

By

Researchers sought to assess the prevalence and characteristics of monophasic disease course in a defined cohort of patients with SLE.

Comparing Factors Associated With Tubulointerstitial Inflammation in Lupus Nephritis

Comparing Factors Associated With Tubulointerstitial Inflammation in Lupus Nephritis

By

Routinely available serologic markers have no correlation with tubulointerstitial damage in patients with lupus nephritis.

Poverty, Neighborhood May Affect Outcomes in Systemic Lupus Erythematosus

Poverty, Neighborhood May Affect Outcomes in Systemic Lupus Erythematosus

By

Outcomes in systemic lupus erythematosus are largely influenced by level of poverty, type of neighborhood of residence, and chronic stress.

SLE-DAS Superior to SLEDAI-2K in Detecting Changes in SLE Disease Activity

SLE-DAS Superior to SLEDAI-2K in Detecting Changes in SLE Disease Activity

By

To assess validity of SLE-DAS, investigators performed a Spearman's correlation between SLE-DAS, PGA, and SLEDAI-2K at the last follow-up visit.

Cardiac Screening May Not Be Beneficial in SLE With Anti-Ro Antibodies

Cardiac Screening May Not Be Beneficial in SLE With Anti-Ro Antibodies

By

Cardiac screening in patients with systemic lupus erythematosus and anti-Ro-positive antibodies does not appear to be beneficial in clinical practice.

Baricitinib Shows Positive Results for Systemic Lupus Erythematosus in Phase 2 Study

Baricitinib Shows Positive Results for Systemic Lupus Erythematosus in Phase 2 Study

By

Baricitinib 4 mg was safe and effective in patients with systemic lupus erythematosus.

Determining Elevated Thrombotic Risk in Systemic Lupus Erythematosus

Determining Elevated Thrombotic Risk in Systemic Lupus Erythematosus

By

Recent data from EULAR 2018 highlight the existence of thrombotic factors in systemic lupus erythematosus.

Obesity May Not Be Associated With Development of Lupus Nephritis

Obesity May Not Be Associated With Development of Lupus Nephritis

By

Obesity is not associated with the development of lupus nephritis among patients with systemic lupus erythematosus.

Examining Trends of Histologic Presentation, Renal Outcomes in Lupus Nephritis

Examining Trends of Histologic Presentation, Renal Outcomes in Lupus Nephritis

By

Investigators sought to evaluate changes in demographic, clinical, and histologic presentation in patients with lupus nephritis between 1970 and 2016.

Anti-dsDNA Antibodies Correlated With Clinical, Laboratory Parameters in SLE

Anti-dsDNA Antibodies Correlated With Clinical, Laboratory Parameters in SLE

By

Female patients with systemic lupus erythematosus who had musculoskeletal symptoms or positive antiphospholipid antibodies demonstrated higher titers of anti-double-stranded DNA antibodies.

Managing Cognitive Dysfunction in Systemic Lupus Erythematosus

Managing Cognitive Dysfunction in Systemic Lupus Erythematosus

By

The pathogenic pathways of SLE-related cognitive dysfunction are yet to be fully elucidated, but vasculopathy, antibody-mediated neurotoxicity, impairments in cytokine signaling, and complement abnormalities have been proposed as contributing factors.

PAH-Associated Connective Tissue Diseases: A Case for Separating SSc, SLE

PAH-Associated Connective Tissue Diseases: A Case for Separating SSc, SLE

By

Recent evidence suggests that systemic sclerosis and SLE in pulmonary arterial hypertension should be considered separate diseases.

Clinician Roundtable: Improving Quality of Life in Systemic Lupus Erythematosus

Clinician Roundtable: Improving Quality of Life in Systemic Lupus Erythematosus

By

Quality of life measurements capture unique information about systemic lupus erythematosus that are not included in disease activity or damage evaluations.

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

Pain, Cognitive Dysfunction in SLE Mediated by Sleep Disturbance, Depression

By

The relationship between pain and cognitive dysfunction was explained by sleep disturbance and depressive symptoms.

Bisphosphonate, Vitamin D Combination Therapy May Prevent Atherosclerosis in SLE

Bisphosphonate, Vitamin D Combination Therapy May Prevent Atherosclerosis in SLE

By

Bisphosphonates and vitamin D may help prevent atherosclerosis in patients with systemic lupus erythematosus.

ACR Provisional Criteria: Global Flares in Childhood-Onset SLE

ACR Provisional Criteria: Global Flares in Childhood-Onset SLE

By

Provisional criteria for global flares in patients with childhood-onset systemic lupus erythematosus are now available from the ACR.

Effects of SLE Diagnosis Examined in Antiphospholipid Antibody-Positive Patients

Effects of SLE Diagnosis Examined in Antiphospholipid Antibody-Positive Patients

By

Researchers compared the clinical, laboratory, and treatment characteristics of antiphospholipid antibody-positive patients with or without SLE.

Repeat Antibody Testing May Be Unnecessary for Some Patients With SLE

Repeat Antibody Testing May Be Unnecessary for Some Patients With SLE

By

Data show that anti-ENA results change infrequently, especially following 1 or more negative tests.

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

By

A 72-year-old Japanese woman with a 40-year history of lupus nephritis presented with leg edema that had lasted for several weeks.

Sign Up for Free e-newsletters